Abstract P029: Non-high Density Lipoprotein Is A Residual Risk For The Progression Of Endothelial Dysfunction In Patients With Well Controlled Low-density Lipoprotein Cholesterol: Multicenter Prospective Study FMDJ Study

Chisa Matsumoto,Hirofumi Tomiyama,Taishiro Chikamori

Abstract P029: Non-high Density Lipoprotein Is A Residual Risk For The Progression Of Endothelial Dysfunction In Patients With Well Controlled Low-density Lipoprotein Cholesterol: Multicenter Prospective Study FMDJ Study

2021

Chisa Matsumoto
Hirofumi Tomiyama
Taishiro Chikamori

Introduction: Recently, several guidelines suggest the usefulness of non-high density lipoprotein cholesterol (non-HDLC) as a secondary treatment target for CVD prevention, next to low-density lipo...

Keywords:

Internal medicine
low density lipoprotein cholesterol
High-density lipoprotein
Endothelial dysfunction
Gastroenterology
Prospective cohort study
in patient
Residual risk
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations